PIK3CD and neoplasm: The effectiveness of the combined targeting of RhoA in tumour cells and p110δ in macrophages was found to be the same either when interference with p110δ activity in macrophages starts concomitantly with (Fig. 2a), precedes (Fig. 2c) or follows (Fig. 2d) the induction of RhoA activity into tumours.